Easing the Agitation Burden: Evidence-Based Approaches to Addressing Agitation Associated With Dementia due to Alzheimer’s Disease

This educational program aims to improve the knowledge, competence, and performance of healthcare professionals in optimizing treatment for patients with agitation associated with dementia (AAD) and Alzheimer’s disease. It targets psychiatrists, neurologists, primary care physicians, physician associates, pharmacists, social workers, and psychologists who manage AAD patients in specialty and primary care practice settings.

Share

Program Content

Activities

AAD MEDX slides
Easing the Agitation Burden: Evidence-Based Approaches to Addressing Agitation Associated With Dementia due to Alzheimer’s Disease
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: September 10, 2024

Expires: September 09, 2025

Faculty

cover img faculity

Anton P. Porsteinsson, MD

William B. and Sheila Konar Professor of Psychiatry, Neurology, Neuroscience, and Medicine
Director, Alzheimer’s Disease Care, Research and Education Program (AD-CARE)
University of Rochester School of Medicine and Dentistry
Rochester, New York

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC, in partnership with the Alzheimer's Foundation of America

Supporters

Supported by an educational grant from Otsuka America Pharmaceutical, Inc. and Lundbeck.

Lundbeck

Otsuka America Pharmaceutical, Inc.

Partners

Alzheimer's Foundation of America

ProCE Banner